Session

Oesophageal, gastric and duodenal disorders (Posters)

CAN HISTOLOGIC ACTIVITY AND EXPERTISE AFFECT THE ACCURACY OF ENDOSCOPIC REFERENCE SCORE (EREFS)?
CAN HISTOLOGIC ACTIVITY AND EXPERTISE AFFECT THE ACCURACY OF ENDOSCOPIC REFERENCE SCORE (EREFS)?

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ACUTE ESOPHAGEAL NECROSIS: A 10-YEAR RETROSPECTIVE SINGLE-CENTER STUDY
ACUTE ESOPHAGEAL NECROSIS: A 10-YEAR RETROSPECTIVE SINGLE-CENTER STUDY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ACUTE UPPER GASTROINTESTINAL BLEEDING IN PATIENTS USING ANTICOAGULANTS: DOES THE TIMING OF ENDOSCOPY AFFECT OUTCOMES?
ACUTE UPPER GASTROINTESTINAL BLEEDING IN PATIENTS USING ANTICOAGULANTS: DOES THE TIMING OF ENDOSCOPY AFFECT OUTCOMES?

Oesophageal, gastric and duodenal disorders (Posters)  et al.

IMPORTANCE OF ENDOSCOPIC DIAGNOSIS FROM THE VIEWPOINT OF THE DISEASE STATE OF BURKITT LYMPHOMA
IMPORTANCE OF ENDOSCOPIC DIAGNOSIS FROM THE VIEWPOINT OF THE DISEASE STATE OF BURKITT LYMPHOMA

Oesophageal, gastric and duodenal disorders (Posters)  et al.

PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH ESOPHAGEAL CANCER- A SINGLE CENTER PROSPECTIVE STUDY
PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH ESOPHAGEAL CANCER- A SINGLE CENTER PROSPECTIVE STUDY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

A SURVEY BASED ASSESSMENT OF MANAGEMENT OF ESOPHAGEAL FOOD IMPACTIONS IN THE US AND EUROPE
A SURVEY BASED ASSESSMENT OF MANAGEMENT OF ESOPHAGEAL FOOD IMPACTIONS IN THE US AND EUROPE

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ODYNOPHAGIA AND RETROSTERNAL PAIN IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS – RATHER INDICATIVE OF DISEASE ACTIVITY THAN SIDE EFFECT OF THERAPY
ODYNOPHAGIA AND RETROSTERNAL PAIN IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS – RATHER INDICATIVE OF DISEASE ACTIVITY THAN SIDE EFFECT OF THERAPY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

SYMPTOM AND QUALITY OF LIFE BURDEN AMONG PATIENTS WITH EOSINOPHILIC OESOPHAGITIS IN A REAL-WORLD SETTING
SYMPTOM AND QUALITY OF LIFE BURDEN AMONG PATIENTS WITH EOSINOPHILIC OESOPHAGITIS IN A REAL-WORLD SETTING

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ADHESION OF GASTRIC CANCER CELLS TO THE ENTERIC NERVOUS SYSTEM IN A NEWLY DEVELOPED CO-CULTURE MODEL: COMPARISON BETWEEN THE INTESTINAL AND DIFFUSE TYPE OF GASTRIC CANCER
ADHESION OF GASTRIC CANCER CELLS TO THE ENTERIC NERVOUS SYSTEM IN A NEWLY DEVELOPED CO-CULTURE MODEL: COMPARISON BETWEEN THE INTESTINAL AND DIFFUSE TYPE OF GASTRIC CANCER

Oesophageal, gastric and duodenal disorders (Posters)  et al.

INCREASED RISK OF BARRETT’S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN INDIVIDUALS WITH A POSITIVE FAMILY HISTORY
INCREASED RISK OF BARRETT’S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN INDIVIDUALS WITH A POSITIVE FAMILY HISTORY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

RISK OF BARRETT’S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS DIAGNOSED WITH BREAST CANCER – A NATIONWIDE STUDY
RISK OF BARRETT’S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS DIAGNOSED WITH BREAST CANCER – A NATIONWIDE STUDY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

USE OF PROTON PUMP INHIBITORS IS ASSOCIATED WITH INCREASED RISK OF GASTRIC CANCER IN COMMUNITY DWELLING ELDERLY
USE OF PROTON PUMP INHIBITORS IS ASSOCIATED WITH INCREASED RISK OF GASTRIC CANCER IN COMMUNITY DWELLING ELDERLY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

SAFETY, EFFICACY, CLOSURE TECHNIQUES AND MEDIUM-TERM OUTCOMES OF ENDOSCOPIC FULL-THICKNESS RESECTION – A DECADE LONG EXPERIENCE FROM A TERTIARY CARE CENTER
SAFETY, EFFICACY, CLOSURE TECHNIQUES AND MEDIUM-TERM OUTCOMES OF ENDOSCOPIC FULL-THICKNESS RESECTION – A DECADE LONG EXPERIENCE FROM A TERTIARY CARE CENTER

Oesophageal, gastric and duodenal disorders (Posters)  et al.

UNDIFFERENTIATED-PREDOMINANT MIXED-TYPE EARLY GASTRIC CANCER IS MORE AGGRESSIVE THAN PURE UNDIFFERENTIATED-TYPE: A META-ANALYSIS
UNDIFFERENTIATED-PREDOMINANT MIXED-TYPE EARLY GASTRIC CANCER IS MORE AGGRESSIVE THAN PURE UNDIFFERENTIATED-TYPE: A META-ANALYSIS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ABERRANT MUC13 EXPRESSION AS PROGNOSTIC MARKER FOR GASTRIC CANCER
ABERRANT MUC13 EXPRESSION AS PROGNOSTIC MARKER FOR GASTRIC CANCER

Oesophageal, gastric and duodenal disorders (Posters)  et al.

COMPLIANCE FOR THE PROSE DAILY DIARY: MEASURING COMPLETION RATES OF A NEW INSTRUMENT TO MEASURE DYSPHAGIA EPISODES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
COMPLIANCE FOR THE PROSE DAILY DIARY: MEASURING COMPLETION RATES OF A NEW INSTRUMENT TO MEASURE DYSPHAGIA EPISODES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ANALYSIS OF QUALITY OF LIFE BY GASTOINTESTINAL QUALITY OF LIFE INDEX GIQLI IN PATIENTS WITH GERD
ANALYSIS OF QUALITY OF LIFE BY GASTOINTESTINAL QUALITY OF LIFE INDEX GIQLI IN PATIENTS WITH GERD

Oesophageal, gastric and duodenal disorders (Posters)  et al.

ELEVATED EPIDERMAL GROWTH FACTOR RECEPTOR LEVELS IN BARRETT'S ESOPHAGUS
ELEVATED EPIDERMAL GROWTH FACTOR RECEPTOR LEVELS IN BARRETT'S ESOPHAGUS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

HYPERPLASIC GASTRIC POLYPS : ABOUT 63 CASES
HYPERPLASIC GASTRIC POLYPS : ABOUT 63 CASES

Oesophageal, gastric and duodenal disorders (Posters)  et al.

HYBRID ARGON PLASMA COAGULATION IN THE ABLATION TREATMENT OF BARRETT´S ESOPHAGUS - LONG TERM RESULTS
HYBRID ARGON PLASMA COAGULATION IN THE ABLATION TREATMENT OF BARRETT´S ESOPHAGUS - LONG TERM RESULTS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

Item 141 - 160 / 165
1 2 3 4 5 6 7
8
9